During a retroactive review of distributor incident files, conducted as a capa in response to a recent fda inspection, a reportable adverse event was discovered.The patient reportedly had an allergic reaction to nickel in the lifevest.The reaction was blistering in large areas and the patient's skin was peeling.The patient visited the er where she was prescribed hydrocortisone (25 mg tablets), and an anti bacterial ointment bacitracin to use along with the steroid prednisone.The patient was also instructed to remove the lifevest periodically and shower in cool water.The medical outcome of the area is unknown.
|